Saudi In-vitro Diagnostics and Digital Pathology Laboratories Study

CLIENT

A Global Fortune 500 company in the Healthcare Diagnostics Industry wanted to conduct a deep-dive analysis of the Saudi healthcare market and desire for public and private players to invest in both digital and brick and mortar laboratories.

ISSUE

The client wanted a market landscape assessment and actionable go-to-market strategy, Solidiance did this by:

• 1) Conducting a thorough Saudi healthcare landscape assessment
• 2) Develop relationships with key opinion leaders in the Saudi healthcare market
• 3) Assess government and private interest in investing in digital pathology laboratires
• 4) Determine upcoming policy changes with the Saudi Health Council and other government bodies that would affect business

APPROACH

Solidiance supported the client by first conducting a deep dive market landscape assessment looking at both the IVD Market, and assessing the appetite for the adoption of digital pathology laboratories. Then, we developed relationships with key opinion leaders and stakeholders in the Saudi market to discuss and build a mutually beneficial business case for advancements in the diagnostic laboratory space. Solidiance then developed an actionable go to market strategy where pitches were made to both public and private healthcare entities in KSA.

ENGAGEMENT ROI

A clear Go To Market Strategy was deployed that included supporting the Saudi Government assess the ROI to policy changes in the diagnostic space. Furthermore, new laboratories were built and pilot digital pathology projects were launched in various esteemed hospital groups across the Kingdom.